Having placed executives into these roles repeatedly, we wrote this to tell you what genuinely matters, not the generic career advice you have already read. Most medical device sales executive resumes read as a list of quota attainment percentages, which tells a hiring company almost nothing about whether you can do the job they are hiring for. The resumes that get device sales leaders interviewed show what they sold, to whom, through what channel, and against what reimbursement and clinical dynamics, because that context is what determines transferability.
Key Takeaways
- Quota percentages alone do not demonstrate transferable capability.
- Show the product type, buyer, channel, and sales cycle you operated in.
- Reimbursement and clinical selling experience is a differentiator.
- Quantify context, territory size, team, cycle length, not just attainment.
- Tailor to the specific device segment you are targeting.
Why Attainment Percentages Are Not Enough
A line reading that you achieved 118 percent of quota tells a reader nothing about the difficulty, the context, or whether the capability transfers. Quota is set internally and varies enormously in how it is calibrated. What a hiring company actually wants to know is what you sold, who bought it, how long the cycle was, what the competitive situation was, and whether the selling motion resembles theirs. A resume built on attainment numbers alone invites the reader to guess at all of this, and readers under time pressure usually guess unfavorably or move on.
Show the Selling Context
The most valuable additions to a device sales resume are contextual: the product category and its risk class, the buyer (surgeon, interventionalist, lab director, materials management, IDN committee), the channel (direct, distributor, hybrid), the typical sales cycle length, the deal size, and whether the sale was capital equipment, disposables, or a mix. These details let a hiring manager assess transferability in seconds. Two candidates with identical attainment numbers can have entirely different profiles, and the one who makes the context explicit is the one who gets evaluated accurately.
Make Reimbursement and Clinical Selling Visible
Device selling frequently turns on reimbursement and clinical evidence, and experience navigating coverage, prior authorization, or economic value conversations with health systems is a genuine differentiator that most resumes omit entirely. If you have driven adoption where coverage was uncertain, built the economic case for a capital purchase, or worked with clinical champions to establish a new procedure, say so specifically. These experiences signal a level of capability well beyond relationship selling, and they are exactly what companies commercializing newer technologies are looking for.
Quantify the Right Things
Quantification helps, but the useful numbers are contextual rather than only attainment: territory or region size, revenue base inherited versus built, team size and structure managed, number of accounts or IDNs, average deal size, cycle length, and growth over a defined period with the starting point stated. Growing a territory from four million to nine million over three years while opening two IDN systems is far more informative than 140 percent of plan. Give the reader the numbers that let them calibrate the scale and difficulty of what you did.
What This Looks Like in Practice
A device sales executive builds a resume around selling context, product category, buyer type, channel, cycle length, deal size, alongside outcomes quantified with their starting points and scale. They make reimbursement, market access, and clinical selling experience explicit, and tailor the emphasis to the specific device segment they are targeting. They do not rely on quota attainment percentages to carry the document.
The Mistake Candidates Keep Making
The most common mistake is building the resume entirely around attainment percentages and award recognition, on the assumption that strong numbers speak for themselves. They do not, because the reader cannot tell how quota was calibrated, what was being sold, or whether the motion transfers. The candidate mistakes internal performance markers for external evidence of capability, and gets screened out by readers who could not assess fit from what was provided.
What to Add Beyond Quota Attainment
| Element | What It Tells the Reader |
|---|---|
| Product category and risk class | Regulatory and clinical complexity you handled |
| Buyer type | Whether the selling motion transfers |
| Channel structure | Direct, distributor, or hybrid experience |
| Cycle length and deal size | Scale and difficulty of the sale |
| Reimbursement involvement | Capability beyond relationship selling |
The Bottom Line
Device sales resumes should show what you sold, to whom, through what channel, and against what reimbursement and clinical dynamics, quantified with real context and starting points, because that is what lets a hiring company judge transferability, which quota attainment percentages alone cannot do. None of this is quick, but it compounds, and the candidates who start early are the ones with options later.
Related Reading
For more, see What Recruiters Look for in MedTech Candidates, How to Land a C-Suite Role in the Medical Device Industry, Preparing for Interviews at Top MedTech Companies.
Frequently Asked Questions
- Q: Why are quota percentages insufficient on a device sales resume?
- A: Because quota calibration varies enormously between companies, so the number alone tells a reader nothing about difficulty, context, or whether your capability transfers to their selling motion.
- Q: What context should I include?
- A: Product category and risk class, buyer type, channel structure, typical cycle length, deal size, and whether you sold capital equipment, disposables, or a mix.
- Q: Does reimbursement experience matter on a resume?
- A: Considerably; experience navigating coverage, prior authorization, or economic value conversations differentiates you and is exactly what companies commercializing newer technologies look for.
- Q: How should I quantify results?
- A: With contextual numbers, territory size, revenue grown from a stated starting point, team size, account or IDN counts, deal size, and cycle length, rather than attainment alone.
- Q: Should I tailor the resume by segment?
- A: Yes; emphasize the experience most relevant to the specific device segment you are targeting, since transferability is what the reader is trying to assess.
![](https://www.jrgpartners.com/wp-content/uploads/2025/12/tanya-gallardo.jpeg")
Tanya Gallardo
Managing Director, Executive Search & AI Talent Strategy
Tanya Gallardo is the Managing Director of Executive Search & AI Talent Strategy at JRG Partners, leading C-suite and Board engagements across key growth sectors including Technology, Financial Services, and Manufacturing.
With over 18 years of experience specializing in disruptive technology leadership, Tanya is recognized as a leading authority on talent architecture for future-focused executive roles, such as the Chief AI Officer (CAIO) and Chief Digital Officer (CDO). Her expertise lies in accurately assessing the cultural fit and technical depth required to ensure a high return on investment (ROI) for critical leadership appointments.
Prior to her role at JRG Partners, Tanya held senior roles directing global talent acquisition strategies at a major publicly-traded technology firm, advising on organizational design and succession planning for emerging executive functions. She is a recognized speaker and contributor to industry events, sharing data-driven insights on executive compensation, leadership development, and the measurable business impact of C-suite talent.
